Courtagen Life Sciences Inc. Enters into an Exclusive Distribution Agreement with the Alliance Global Group

  Courtagen Life Sciences Inc. Enters into an Exclusive Distribution Agreement
  with the Alliance Global Group

   **Expansion into Emerging Markets with Courtagen’s Molecular Diagnostics
                                    Menu**

Business Wire

DUBAI & WOBURN, Mass. -- November 15, 2012

Courtagen Life Sciences Inc. announced today they have signed an exclusive
strategic distribution agreement with the Alliance Global Group (AGBL) to help
clinicians in emerging markets diagnose and manage a number of genetically
based disorders. Courtagen’s test menu currently offers clinical tests for
mitochondrial disorders (mtSEEK™ and nucSEEK™) and a newly released panel for
epilepsy and seizure (epiSEEK™). Courtagen plans to add a number of key tests
for other important neurological disorders.

“Building this relationship with AGBL is a critical component of Courtagen’s
international business expansion,” said Brian McKernan, CEO, Courtagen Life
Sciences, Inc.

Courtagen’s CLIA Laboratory genetic tests use next generation sequencing (NGS)
technology, propriety bioinformatics platform, ZiPhyr™ and state of the art
analytic capabilities to accurately sequence patient’s DNA and translate the
sequence data into highly useful, clinically relevant information for
physicians. Additionally, Courtagen’s protein diagnostics division offers
decentralized testing of protein biomarker to simplify pre-clinical and
clinical trial protocols.

“We are pleased to enter into this agreement with Courtagen,” said Dr. Tamer
Degheidy, CEO of Alliance Global. “Courtagen’s portfolio of genetic tests will
certainly have a positive impact on patients’ diagnosis and management in
markets covered by our group.”

About Courtagen Life Sciences Inc.
Based in Woburn, Massachusetts (USA), Courtagen Life Sciences is a privately
held life sciences company that provides innovative proteomic and genomic
products and services to the life sciences industry. Founded by innovators in
next-generation sequencing, genetics, molecular biology, and information
science, the company delivers tools to enable researchers and clinicians to
make better decisions regarding drug development and patient care. For more
information, please visit: www.courtagen.com

About Alliance Global Group (AGBL)
The AGBL Group of companies is the largest biomedical gateway to the emerging
markets of Middle East, Africa and Asia. The group is dedicated to bringing
the latest technologies and products to researchers, clinicians, diagnostic
users and healthcare providers in the markets it covers. The group employs
more than 80 specialists and has six regional offices offering distribution,
consultation and product development services. The company helps biomedical
technology manufacturers and suppliers introduce their products and services
to emerging markets, reflecting on the healthcare standards within those
markets. For more information, please visit: www.agbl.net

Contact:

Courtagen Life Sciences Inc.
Elizabeth Holland, +1 617-892-7178
Vice President, Business Operations
Elizabeth.holland@courtagen.com
or
Alliance Global Group
info@agbl.net